SPase I/LepB inhibitor arylomycin antibiotics (Genentech)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSPase I/LepB inhibitor arylomycin antibiotics (Genentech)

Drug Alias NameLepB inhibitors (Genentech)SPase I inhibitors (Genentech)leader peptidase inhibitors (Genentech)type I signal peptidase inhibitors (Genentech)GDC-55338

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics

Mechanisms of Actiontype I signal peptidase inhibitors

Targetstype I signal peptidase

Therapy Area/IndicationsKlebsiella InfectionsEscherichia coli InfectionsEnterobacteriaceae Infections +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsKlebsiella InfectionsEscherichia coli InfectionsEnterobacteriaceae Infections +[4]

Other Information

ATC CodeN/A